TWI286547B - Ionic molten salt and method of producing the same - Google Patents

Ionic molten salt and method of producing the same Download PDF

Info

Publication number
TWI286547B
TWI286547B TW90132421A TW90132421A TWI286547B TW I286547 B TWI286547 B TW I286547B TW 90132421 A TW90132421 A TW 90132421A TW 90132421 A TW90132421 A TW 90132421A TW I286547 B TWI286547 B TW I286547B
Authority
TW
Taiwan
Prior art keywords
compound
group
alkyl
organic
substituent
Prior art date
Application number
TW90132421A
Other languages
Chinese (zh)
Inventor
Tun-Fun Way
Wen-Yueh Ho
Frank L Chen
Original Assignee
Ind Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Tech Res Inst filed Critical Ind Tech Res Inst
Priority to TW90132421A priority Critical patent/TWI286547B/en
Application granted granted Critical
Publication of TWI286547B publication Critical patent/TWI286547B/en

Links

Abstract

A novel ionic molten salt of the structure: wherein R1 is selected from the group consisting of -(CH2)x- and the linear or branched isomers thereof, wherein x is 1 to 10; R2 is selected from -(CH2)pH and the isomers thereof; p is 1 to 20; A is an organic or inorganic anionic moiety and selected from the group consisting of R3CO2-, BF4, and PF6; and R3 is an alkyl group having 1 to 3 carbon atoms, phenyl, naphthyl, biphenyl, an aliphatic fluorocarbon group, or an aromatic fluorocarbon group.

Description

i 1286547 玖、發明說明: 【發明所屬之技術領域】 本發明係有關於一種新穎型離子溶體(Ionic molten salt)以 及其製備方法,特別有關於一種同時含有吡啶鐺(Pyridinium)以 及咪σ坐鎗(Imidazolium)兩種正離子基團的離子溶體。 【先前技術】 離子溶液(ionic liquid)又稱為熔鹽(molten salts),其一般結 構是由有機正離子與無機負離子基團所組成。上述兩種正負離 子之結合,可得到許多不同熔點範圍之化合物。 離子溶液近年來之所以受到重視,乃因為其具有下列特性: 1·對有機或無機化合物具有大範圍之溶劑特性; 2·具有高的極性特質,可稱為非水溶液型的極性溶劑; 3. 有些與有機溶劑.及水溶液皆不互溶; 4. 揮發性低,可用低真空方法除去雜質; 5·與一般溶劑比較,具有不易燃及耐熱性高之優勢。 由於上述之特點,目前離子熔體已應用於電解質、溶劑以 及催化劑方面。就财熱性以及炫點之控制來說,目前較被廣泛 應用的有機正離子化合物為味峻(Imidazole)以及吼σ定(pyridine) 之衍生物。在近期發表之Chem. Review,1999,99,2071 之’’Room-temperature Ionic liquids: solvents for synthesis and catalysis”中有相當詳盡之報導。美國專利第5,827,602號(1998 年)及第6,025,457號(2000年)所揭露的離子熔體之化學結構都 是含單一吡啶或咪唑正離子基團。而美國R. G. Reddy等人之文 獻(ASME Proceedings of Solar Forum 2001,Washington DC, April 21-25, 2001年)中報告,改變負離子基團,可以大幅度降 12865^7 132421號專利說明書修正頁 修正日期:93.10.18 .: , 低離子熔體之熔點,例如:乙基曱基味°坐•六氟化石粦 (Ethylmethylimidazolium · PF6)之溶點溫度(Tm)=60°C,但是乙 基甲基口米唾.醋酸基作1:]171111^1;113^1111(132〇1]^111*^/^〇〇〇)之溶點 溫度(Tm)= -45QC,兩者之熔點溫度差距可以達到100°C以上。 另外,R· G· Reddy等也同時發現利用混合不同種類之正離 子基團及負離子基團之離子熔體,可以得到最佳之熔點及耐熱 性之離子熔體混合物,例如:混合50%之丁基甲基咪唑· BF4 (Butylmethylimidazolium · BF4)(熱裂解溫度 Tdee=407QC)及 50% 之己基甲基咪唑•雙-[(三氟甲基磺酸)亞胺] [Hexylmethylimidazolium bis(trifluoromethylsulfonyl) imide (簡 稱NTf2)](熱裂解溫度Tdee=341°C)得到較高之熱裂解溫度之離 子熔體混合物(熱裂解溫度Tdec^427QC)。目前正將此混合離子熔 體當作熱能貯藏介質,使用於太陽熱電能系統中。 另外 R· Hagiwara 等人之論文:J. 〇f Fluorine Chem·,第 105 期,第221頁(2000年),也提到摻混兩種不同之離子熔體,可 以得到新功能性質之新離子溶體’及較低溫度之共溶點(eutectic point) 〇 但是依據我們之經驗,以不同比例之咪唑鐺· BF4 (imidazolium · BF4)以及吡啶鏺· BF4 (pyridinium · BF4)混合做 為離子熔體,在實用上,會發生兩種離子溶體之部份相分離的 現象’此現象很谷易攸目視即可以觀祭到,而導致反·應之環境 不穩定變化。由於單獨之咪唑或吡啶為正離子基團之離子熔體 之熔點變化,受限於接於旁侧之烷基取代物之有限種類的限 制,故可調整其溶點或溶劑性質的能力也很有限。此外,咪唑 基以及吡啶基之烷基取代基,也佔去此化合物相當大的空間。 再者,習知有關芳香族胺類鹽之離子熔體的化學結構其正 1286547 h ί * 、 離子基團僅含-咪唑或吡啶之化學基團。欲改變此鹽類之熔點, 除了改變負離子基團種類外,需要以不同之熔點基團或不對稱 之側鏈基團接合於此正離子基團結構上,才能得到改變或降低 熔點之效果。但是龐大不對稱之側鏈基團也使離子熔體的體積 升高,故而造成單位體積内離子濃度特性之降低。此報告可見 於P_ Bonhote等人之論文:inorg· Chem,第35期,第1168頁 (1996 年)及 R.Hagiwara 等人之論文:j· 〇mu〇rine chem.,第 105期,第221頁(2000年)所示。 【發明内容】 有鑑於此,本發明提供一種以一般共聚合化合物之方法將 咪唑鎗以及吡啶鎗同時置於同一化合物上,如此咪唑及吡啶之 比例不會隨著環境之變化而改變,同時該化合物具有相當大的 不對稱分子結構,加上共同使用烷基化合物的緣故,可使單位 體積内的離子密度大增,減低烷基所佔空間。此種新穎的離子 込體結合咪唑及吡啶兩種基團的特性,可擴充對目前既知技術 報告之將離子熔體使用於溶液、電解質及催化反應方面之應 用’例如’做為具離子性試劑之反應介質或溶劑及儲能電池之 電解質等。 為了達成本發明,本發明之製備離子熔體的方法,其包括 (a)將吡啶與具取代基B之烷類或醚類化合物(化合物u反應得化 合物II ;i 1286547 玖, invention description: [Technical field of the invention] The present invention relates to a novel ion salt (Ionic molten salt) and a preparation method thereof, and more particularly to a method comprising simultaneously containing pyridinium and yttrium An ionic solution of two positive ion groups of the gun (Imidazolium). [Prior Art] An ionic liquid is also called a molten salt, and its general structure is composed of an organic positive ion and an inorganic negative ion group. A combination of the above two kinds of positive and negative ions can give a plurality of compounds having different melting point ranges. Ion solutions have received much attention in recent years because of their following characteristics: 1. A wide range of solvent properties for organic or inorganic compounds; 2. High polarity properties, which can be called non-aqueous solutions of polar solvents; Some are not miscible with organic solvents and aqueous solutions; 4. Low volatility, low-vacuum method can be used to remove impurities; 5. Compared with general solvents, it has the advantages of low flame resistance and high heat resistance. Due to the above characteristics, ionic melts have been applied to electrolytes, solvents, and catalysts. For the control of the heat and the control of the bright spot, the currently widely used organic cation compounds are derivatives of Imidazole and pyridine. There is a fairly detailed report in the recently published Chem. Review, 1999, 99, 2071 "Room-temperature Ionic liquids: solvents for synthesis and catalysis." U.S. Patent Nos. 5,827,602 (1998) and 6,025,457 (2000). The chemical structure of the ionic melts disclosed in the year is a single pyridine or imidazole cation group. The RG Reddy et al. (ASME Proceedings of Solar Forum 2001, Washington DC, April 21-25, 2001) It is reported that changing the negative ion group can greatly reduce the modification date of the patent specification of 12865^7 132421. Revision date: 93.10.18 .: , the melting point of low ionic melt, for example: ethyl oxime taste ° sitting • hexafluoride The melting point temperature (Tm) of 粦(Ethylmethylimidazolium·PF6)=60°C, but ethylmethyl sulphate. The acetate group is 1:]171111^1; 113^1111(132〇1]^111*^/ ^〇〇〇) The melting point temperature (Tm) = -45QC, the melting point temperature difference between the two can reach 100 ° C or more. In addition, R·G·Reddy et al. also found that the use of different types of positive ion groups and An ionic melt of an anion group, An ionic melt mixture with optimum melting point and heat resistance, for example: 50% butylmethylimidazolium BF4 (Butylmethylimidazolium BF4) (thermal cracking temperature Tdee=407QC) and 50% hexylmethylimidazole•double- [(Trifluoromethylsulfonyl)imide] [Hexylmethylimidazolium bis(trifluoromethylsulfonyl) imide (NTf2)] (thermal cracking temperature Tdee=341°C) to obtain a higher thermal cracking temperature of the ionic melt mixture (thermal cracking temperature) Tdec^427QC). This mixed ion melt is currently being used as a thermal energy storage medium for solar thermal energy systems. Also by R. Hagiwara et al.: J. 〇f Fluorine Chem·, No. 105, p. 221 (2000), also mentioned the incorporation of two different ionic melts, which can give new functional properties of new ionic solutions' and lower temperature eutectic points, but according to our experience, different The ratio of imidazolium BF4 (imidazolium BF4) and pyridinium BF4 (pyridinium BF4) are mixed as ionic melts. In practice, some phase separation of two ionic solutions occurs. Yau Valley phenomenon is easy to sacrifice visual concept that is to be, it should lead to anti-unstable environment changes. Since the melting point of the ionic melt of the imidazole or pyridine alone is limited by the limited kinds of alkyl substituents attached to the side, the ability to adjust the melting point or solvent properties is also very high. limited. In addition, the imidazolyl group and the alkyl substituent of the pyridyl group also occupy a considerable space for the compound. Furthermore, it is known that the chemical structure of an ionic melt of an aromatic amine salt is 1286547 h ί * , and the ionic group contains only a chemical group of -imidazole or pyridine. In order to change the melting point of the salt, in addition to changing the kind of the negative ion group, it is necessary to bond the positive ion group structure with a different melting point group or an asymmetric side chain group to obtain the effect of changing or lowering the melting point. However, the large asymmetric side chain groups also increase the volume of the ionic melt, thereby causing a decrease in ion concentration characteristics per unit volume. This report can be found in the paper by P_ Bonhote et al.: inorg. Chem, No. 35, p. 1168 (1996) and R. Hagiwara et al.: j. 〇mu〇rine chem., No. 105, 221 Page (2000) is shown. SUMMARY OF THE INVENTION In view of this, the present invention provides an imidazole gun and a pyridine gun simultaneously placed on the same compound by a method of generally copolymerizing a compound, such that the ratio of imidazole and pyridine does not change with the environment, and The compound has a relatively large asymmetric molecular structure, and together with the use of the alkyl compound, the ion density per unit volume is greatly increased, and the space occupied by the alkyl group is reduced. The novel ionomers combine the properties of both imidazole and pyridine groups to extend the use of ionic melts for solutions, electrolytes and catalytic reactions reported in the prior art. For example, as an ionic reagent. The reaction medium or solvent and the electrolyte of the energy storage battery. In order to attain the present invention, the method for preparing an ionic melt of the present invention comprises the steps of: (a) reacting pyridine with alkane or an ether compound having a substituent B (compound u to obtain compound II;

B-R1—B 化合物IB-R1-B Compound I

化合物II 128654印132421號專利說明書修正頁 修正曰期:94.8.4 (b)將化合物II純化後與具取代基R2之咪唾(化合物111)Compound II 128654 Print 132421 Patent Specification Revision Page Revision 94:8.4 (b) Purification of Compound II with the Substituted R2 Sodium (Compound 111)

Γ\ R2 化合物III 反應得到含有口米σ坐鐺(imidaz〇Hum salts)及吼σ定鎗(PyHdinium salts)的烷類或醚類化合物IV ;Γ \ R2 compound III is reacted to obtain an alkane or ether compound IV containing imidaz〇Hum salts and PyHdinium salts;

以及(c)將化合物IV與有機或無機之金屬化合物MA反應’而得 如化合物V所示之離子熔體。 (包"―妙、)2,And (c) reacting the compound IV with an organic or inorganic metal compound MA to obtain an ionic melt as shown by the compound V. (Package " "Miao," 2,

化合物V 或者,本發明之另一製備離子熔體的方法包括:(a)將具取 代基R2之咪唑(化合物111)與具取代基B之烷類或醚類化合 物反應而得一化合物VI ;Compound V Alternatively, another method of preparing an ionic melt of the present invention comprises: (a) reacting an imidazole having a substituent R2 (compound 111) with an alkane or ether compound having a substituent B to obtain a compound VI;

化合物VI (b)將化合物VI純化後與吡淀反應得到含有咪唑鍚(imidazolium salts)及吡啶鐵(pyridiniumsalts)的烧類或醚類化合物IV;以及(c) 將化合物IV與有機或無機之金屬化合物Μ A反應,而得如化合 0424-733 lTWF4;02900040;Phoebe 9 1286547 物v所示之離子溶體。 上述方法之該具取代基B之烷類或醚類化合物(化合物 〇 ’ Ri 為-(CH2)x-或-(CH2[-〇-(CH2)y]Z-,其中 B 為相同或不同 齒素’擇自於F、a、Br、I及〇S03R4,而叉為i〜1〇,丫為i〜4, z為1〜1〇 〇 〇 至於該有機或無機之金屬化合物μα係為rc〇2M、 RS03M、MBF4、MPF6 或 MCF3s〇3,其中 M 為擇自 Ag、Li、 H或NH4,而R2為烧基、芳香基或該等相對應之氣類取 代基。 適用於上述方法之具取代基&之咪唑中,尺2為_(〇112)1)11 或其異構物,其中p為1〜20。 又,本發明之新穎的離子熔體其結構如下: ((^N-Ri-辱、Compound VI (b) is purified from compound VI and reacted with pyridinium to obtain a burned or etherated compound IV containing imidazolium salts and pyridinium salts; and (c) compound IV with an organic or inorganic metal The compound Μ A is reacted to obtain an ionic solution such as the compound 0424-733 lTWF4; 02900040; Phoebe 9 1286547. The alkane or ether compound having the substituent B of the above method (the compound 〇' Ri is -(CH2)x- or -(CH2[-〇-(CH2)y]Z-, wherein B is the same or different teeth The prime is selected from F, a, Br, I and 〇S03R4, and the fork is i~1〇, 丫 is i~4, z is 1~1〇〇〇, and the organic or inorganic metal compound μα is rc 〇2M, RS03M, MBF4, MPF6 or MCF3s〇3, wherein M is selected from Ag, Li, H or NH4, and R2 is a burnt group, an aromatic group or the corresponding gas-based substituents. In the imidazole having a substituent & immortal, the rule 2 is _(〇112)1)11 or an isomer thereof, wherein p is from 1 to 20. Further, the novel ionic melt of the present invention has the following structure: ((^ N-Ri-disgrace,

2A Θ 其中H(CH2)X…卿2[_〇仰咖㈣及料㈣應化合物 之直鏈或分鏈異構物,其中\為㈠❹巧為i〜4,z為L·,而 R2為-(CH2)pH以及該化合物之異構物,其中p為i〜2Q ; A為有 機或無機負離子基團。詳而言之,上式t “R3C02_、R3S03-、 為碳數1〜3之燒m mn 化合物或方香族碳氟化合物。 根據本發明提供之離子㈣,其正離子基團同時含有㈣ 及D比唆兩種基團,其優點有: 1. 不對稱性增加,更有效改變此鹽類m 2. 早位體積内離子特性相對增加,增擴其應用面; 3. 此鹽類可同時含有兩種不同之陰離子基團,相對有效改 0424-733 lTWF4;02900040;Phoeb< 10 1286547 變其溶點之範圍; 4.具有同時含味嗤鹽及吼°定鹽之混合效應,卻可避免因為 混合咪唑鹽及吡啶鹽而造成相分離之產生。 【實施方式】 為了讓本發明之上述目的、特徵和優點更明顯易懂,下文 特舉出較佳實施例,並配合所附圖示,作詳細說明如下: 實施例 實施例1. (1)化合物II之合成 將二溴丙烧(1.01 g,5.Ommol)放於反應瓶中,於室溫下緩十黑 加入D比咬(〇.43g,5_5mmol),兩小時後固體慢慢析出,搜掉隔夜 (約1 Ohr) ’將固體以刮构授散’加入丙綱(acetone)並授拌三十分 鐘,快速過濾,並以丙酮清洗固體,然後快速收集固體於反應 瓶中(固體於空氣中會快速潮解),於真空幫浦中抽乾。可獲得 熔點=138 °C的化合物II。其反應式如以下所示:2A Θ where H(CH2)X... Qing 2[_〇仰咖(四)和料(四) should be a linear or branched isomer of a compound, where \ is (a) ❹巧为i~4, z is L·, and R2 is - (CH2) pH and an isomer of the compound, wherein p is i~2Q; A is an organic or inorganic anion group. Specifically, the above formula t "R3C02_, R3S03-, is a calcined m mn compound having a carbon number of 1 to 3 or a scented fluorocarbon. The ion (IV) provided according to the present invention has a positive ion group containing (4) and D has two advantages over the two groups: 1. The asymmetry increases, and the salt m is more effectively changed. 2. The ion characteristics in the early volume are relatively increased, and the application surface is enlarged; 3. This salt can simultaneously Contains two different anionic groups, relatively effective to change 0424-733 lTWF4; 02900040; Phoeb< 10 1286547 to change its melting point range; 4. It has a mixed effect of simultaneously containing miso salt and 吼° fixed salt, but can avoid The phase separation is caused by the mixing of the imidazolium salt and the pyridinium salt. [Embodiment] In order to make the above objects, features and advantages of the present invention more apparent, the preferred embodiments are illustrated below, The details are as follows: EXAMPLES Example 1. (1) Synthesis of Compound II Dibromopropene (1.01 g, 5.0 mmol) was placed in a reaction flask, and D was bitten at room temperature. .43g, 5_5mmol), after two hours, the solid slowly precipitated and was searched overnight ( Approximately 1 Ohr) 'Add solids to the scrape' to the acetone and mix for 30 minutes, quickly filter, and wash the solids with acetone, then quickly collect the solids in the reaction flask (solids will quickly in the air) Deliquescent), drained in a vacuum pump. Compound II with melting point = 138 °C is obtained. The reaction formula is as follows:

以核子共振儀(NMR)以及遠紅外線(IR)測量化合物II,其 數據如下: 1HNMR(400MHz5 D2〇/DMSO/ppm): 8.94(d,2H),8.62(t,1H), 8.15(t,2H),4.81(t,2H),3-49(t,2H),2.60(m,2H) IR: 3054, 2964, 1643, 1488, 1178, 775, 683 cm·1 (2)化合物IV(負離子為Br一)之合成(經由化合物II製得) 0424-733 lTWF4;02900040;Phoebe 11 1286547 “充本,_ h 將化合物II (1 .Og,3.59mmol)以5ml甲^醇為解,和ΛCompound II was measured by nuclear resonance (NMR) and far infrared (IR) with the following data: 1H NMR (400 MHz 5 D2 〇 / DMSO / ppm): 8.94 (d, 2H), 8.62 (t, 1H), 8.15 (t, 2H), 4.81 (t, 2H), 3-49 (t, 2H), 2.60 (m, 2H) IR: 3054, 2964, 1643, 1488, 1178, 775, 683 cm·1 (2) Compound IV (negative ion) Synthesis of Br-) (made by compound II) 0424-733 lTWF4; 02900040; Phoebe 11 1286547 "Filling, _ h Compound II (1.Og, 3.59mmol) with 5ml of methyl alcohol as solution, and Λ

基-咪。坐(〇.35g,4.30mmol),授拌8hr後加入適量丙酮搜拌三十 分鐘洗滌,接著靜置冰浴10分鐘,快速過濾(固體於空氣中會 快速潮解),再以丙酮(2 ml)洗固體,然後快速收集固體於反應 瓶中,於真空幫浦中抽乾,可獲得化合物IV,其反應式如下所Base - microphone. Sit (〇.35g, 4.30mmol), mix for 8hr, add appropriate amount of acetone and mix for 30 minutes, then let the ice bath for 10 minutes, quickly filter (the solid will quickly deliquesce in the air), then acetone (2 ml The solid is washed, and then the solid is quickly collected in a reaction flask and drained in a vacuum pump to obtain a compound IV having the following reaction formula.

rN—CH2CH2CH2BrrN-CH2CH2CH2Br

I—ch3I-ch3

。該化合物IV的熔點為144°C。 以核子共振儀(NMR)以及遠紅外線(IR)測量化合物IV, 其數據如下: 1HNMR(400MHz? D20/DMS0-d6/ppm): 8.87(d5 2H); 8.45(t? 1H); 7.97(t,2H); 7.34(m,3H); 4.60(t,2H); 4.26(t,2H);3.76(s,3H); 2.53(m? 2H). IR: 3086, 1635, 1576, 1489, 1170, 773, 683 cnT1 (3)BFr取代Bf之反應(合成化合物V (負離子為BFD): 將化合物IV置於反應瓶中,加入MeOH,接著再加入過量 (3當量莫耳)之AgBF4反應3天。過濾後將溶液抽乾。加入乙醇 離心,分離鹽類副產物。得到負離子基團為BFr之離子熔體(化 合物V)。熔點=93°C。 0424-733 lTWF4;02900040;Phoebe 12 1286547. The compound IV had a melting point of 144 °C. Compound IV was measured by nuclear resonance (NMR) and far infrared (IR) with the following data: 1H NMR (400 MHz? D20/DMS0-d6/ppm): 8.87 (d5 2H); 8.45 (t? 1H); 7.97 (t , 2H); 7.34 (m, 3H); 4.60 (t, 2H); 4.26 (t, 2H); 3.76 (s, 3H); 2.53 (m? 2H). IR: 3086, 1635, 1576, 1489, 1170 , 773, 683 cnT1 (3) Reaction of BFr in place of Bf (synthesis of compound V (negative ion is BFD): Compound IV was placed in a reaction flask, MeOH was added, and then an excess (3 equivalents of mole) of AgBF4 was added for 3 days. After filtration, the solution was drained, centrifuged with ethanol, and the by-product of the salt was separated to obtain an ionic melt (compound V) having a negative ion group of BFr. Melting point = 93 ° C. 0424-733 lTWF4; 02900040; Phoebe 12 1286547

以核子共振儀(NMR)以及遠紅外線(IR)測量化合物v 其數據如下: iHNMR (400MHz,D20/DMS0-d6/ppm): 8.87(d,2H); 8.76(s 1H) 8.61(t,1H); 8.13(t,2H); 7.50(m,2H); 4.74(t,2H); 4.4l(t,2h): 3.92(s? 3H); 2.68(m? 2H). 5 IR: 3159, 2986, 1635, 1580, 1490, 1219cm·1 (4) PF厂取代Bf之反應(合成化合物VII(負離子為 …一使用過量(3當量莫耳)之AgPF6 將化合物IV置於反應瓶中,加入MeOH,接著再加入過旦 (3當量莫耳)之AgPF6,反應3天。過濾後將溶液抽乾。加人乙 醇離心,分離鹽類副產物。得到負離子基團為PFr之離子 (化合物VII)。熔點=126°C。The compound v was measured by nuclear resonance (NMR) and far infrared (IR). The data is as follows: iHNMR (400 MHz, D20/DMS0-d6/ppm): 8.87 (d, 2H); 8.76 (s 1H) 8.61 (t, 1H) 8.13(t,2H); 7.50(m,2H); 4.74(t,2H); 4.4l(t,2h): 3.92(s? 3H); 2.68(m? 2H). 5 IR: 3159, 2986, 1635, 1580, 1490, 1219cm·1 (4) Reaction of PF plant in place of Bf (Synthesis of compound VII (negative ion is used as an excess (3 equivalents of molar) of AgPF6. Compound IV was placed in a reaction flask and MeOH was added. Then, AgPF6 was added (3 equivalents of mole) for 3 days. After filtration, the solution was drained, and the product was separated by centrifugation with ethanol to obtain a salt by-product, and an ion having a negative ion group of PFr (compound VII) was obtained. Melting point = 126 ° C.

以核子共振儀(NMR )以及遠紅外線(IR )測量化合物 VII,其數據如下: !HNMR (400MHz,D20/DMS0-d6/ppm) ·· 9.08(d,2H); 8.12(S,1H), 8.31(t,1H); 8.00(t,2H); 7.41(m,2H); 4.70(t,2H); 4.24(t,2H); 3.84(s,3H); 2.49(m,2H). IR(KBr): 3435, 3174, 3124, 1673, 1581,1566, 1492, 1457, 1436, 1353, 1174, 1113, 835, 624, 558 cm.1The compound VII was measured by a nuclear resonance (NMR) and far infrared (IR) data as follows: !HNMR (400 MHz, D20/DMS0-d6/ppm) ·· 9.08 (d, 2H); 8.12 (S, 1H), 8.31(t,1H); 8.00(t,2H); 7.41(m,2H); 4.70(t,2H); 4.24(t,2H); 3.84(s,3H); 2.49(m,2H). IR (KBr): 3435, 3174, 3124, 1673, 1581, 1566, 1492, 1457, 1436, 1353, 1174, 1113, 835, 624, 558 cm.1

元素分析理論值:C12H17F12N3P2 (493.07) : C 29·22; H 3.47; N 0424-733 lTWF4;02900040;Phoebe 13 I補朴轉Theoretical value of elemental analysis: C12H17F12N3P2 (493.07): C 29·22; H 3.47; N 0424-733 lTWF4; 02900040; Phoebe 13 I

取代Br 一之反應(合成化合物VIII (負離子為b 1286547 8·52·實驗值 C 29.32;H3.96;N8.59%· (5) PF6-—)) 使用少量(0.5當量莫耳)之AgPF6 將化合物IV置於反應瓶中,加入MeOH,接著再加人小曰 (0.5當量莫耳)之AgPF6,反應3天。過濾後將溶液抽乾。加入 醇離心,分離鹽類副產物。得到負離子基團為pFr之離子、溶體 (化合物VIII)。熔點=110°c。Replacing Br-reaction (synthesis of compound VIII (negative ion b 1286547 8·52·experimental value C 29.32; H3.96; N8.59%·(5) PF6-—)) using a small amount (0.5 equivalent mol) of AgPF6 Compound IV was placed in a reaction flask, MeOH was added, followed by addition of human hydrazine (0.5 eq. mol) of AgPF6 for 3 days. After filtration, the solution was drained. The alcohol by centrifugation was carried out to separate the salt by-product. An ion having a negative ion group of pFr and a solution (Compound VIII) were obtained. Melting point = 110 ° C.

以核子共振儀(NMR )以及遠紅外線(IR )測量化合物 VIII,其數據如下: iNMR (400MHz,D20/DMS0-d6/ppm): 9.00(d,2H);,8·31(ιη,4H); 7.41(m,2H); 4.50(t,2H);4.24(m,2H); 3.84(m,3H); 2.49(m,2H). IR(KBr) : 3435, 3174, 1663, 1581,1566, 1490, 1436, 1174, 1113, 829, 674, 558 cm·1 實施例2.化合物V (負離子為CF3COO一)之合成 步驟(1)及(2)與實施例1相同,惟第(3)步驟,以CF3COCT替 代實施例1中之BF4—: 將AgOCOCF3 (2eq)加入化合物IV的RO水溶液中,接著 放入預熱70°C的油鍋中反應,反應三小時後將大部分固體濾 掉,以RO水稀釋濾液後,以離心機離心,得澄清液,接著濃 縮,乾燥可獲得產物。得到負離子基團(A)為CF3COO—之離 子熔體(化合物V)。熔點=18°C。Compound VIII was measured by nuclear resonance (NMR) and far infrared (IR) with the following data: iNMR (400 MHz, D20/DMS0-d6/ppm): 9.00 (d, 2H);, 8·31 (ιη, 4H) 7.41(m,2H); 4.50(t,2H); 4.24(m,2H); 3.84(m,3H); 2.49(m,2H). IR(KBr) : 3435, 3174, 1663, 1581,1566 , 1490, 1436, 1174, 1113, 829, 674, 558 cm·1 Example 2. Synthesis of Compound V (negative ion is CF3COO-) Steps (1) and (2) are the same as in Example 1, except for (3) Step, replacing BF4 in Example 1 with CF3COCT: Add AgOCOCF3 (2 eq) to the RO aqueous solution of Compound IV, and then put it into the oil pan preheated at 70 ° C, and filter most of the solids after three hours of reaction. After diluting the filtrate with RO water, it was centrifuged to obtain a clear liquid, followed by concentration and drying to obtain a product. An ion melt (compound V) having an anion group (A) of CF3COO was obtained. Melting point = 18 ° C.

以核子共振儀(NMR)以及遠紅外線(IR)測量化合物V 14 0424-733 lTWF4;02900040;Ph〇ebe 1286547 IR: 3090, 1794, 1694, 1578, 1493, 1200cm-1 元素分析:C16H17F6N304分子量:429.31理論值C 44·76%; N 9.7%; F 26.55% 實驗值 C44.1%; N 9.5%,F 26.9% 實施例3. (1)化合物VI之合成 將二溴丙烷(2.02g,lOmmol)放於反應瓶中,於室溫下緩慢 加入N-甲基-咪唑(0.90g,llmmol),攪拌隔夜12小時後,析出 固體,將反應瓶加入丙酮並攪拌三十分鐘,快速過濾,再以丙 酮洗固體,再於真空幫浦中抽乾。可獲得化合物VI。熔點=149 °C。The compound V 14 0424-733 lTWF4; 02900040; Ph〇ebe 1286547 IR: 3090, 1794, 1694, 1578, 1493, 1200 cm-1 Elemental analysis: C16H17F6N304 Molecular weight: 429.31 was measured by nuclear resonance (NMR) and far infrared (IR). Theoretical value C 44·76%; N 9.7%; F 26.55% Experimental value C44.1%; N 9.5%, F 26.9% Example 3. (1) Synthesis of compound VI Dibromopropane (2.02 g, 10 mmol) Put in a reaction flask, slowly add N-methyl-imidazole (0.90 g, llmmol) at room temperature, stir for 12 hours, precipitate a solid, add the reaction flask to acetone and stir for 30 minutes, quickly filter, then The solid was washed with acetone and then drained in a vacuum pump. Compound VI is available. Melting point = 149 °C.

以核子共振儀(NMR )以及遠紅外線(IR )測量化合物 VI,其數據如下: iHNMR (200MHz,D20/DMS0_d6/ppm): 8_81(s,1H),7.55 (m,2H); 4.41(m,3H); 3.93(s,3H); 3.46(t,1H); 2.55(m,2H) IR : 3069, 2965, 1634, 1563, 1465, 1169 cm“ (2)化合物IV(負離子為Br_)之合成(經由化合物VI製得) 將化合物VI (1.42g,5.0mmol)以5ml甲醇溶解,加入D比13定 (0.47g, 6.0mmol),攪拌14hr後加入適量丙酮授拌三十分鐘洗 滌,接著靜置冰浴20分鐘後快速過濾,再以丙酮(5ml)洗固體, 然後收集固體於反應瓶中,於真空幫浦中抽乾,可獲得化合物 IV,其1HNMR資料與實施例1相同。 將上述製得化合物II、IV、V、VI、VII以及VIII的熔點 列於下表: 丨爹正 1286547 I補充 牙 然後收集固體於反應瓶中,於真空幫浦中 IV,其1HNMR資料與實施例1相同。 將上述製得化合物II、IV、V、VI、VII以及VIII的熔點 列於下表: 化合物種類 熔點Tm(°C) 化合物II 138 化合物IV (負離子為Br~") 144 化合物V (負離子為 CF3COO—) 18 化合物VI 149 化合物V (負離子為BF〇 93 化合物VII (負離子為PF「) 126 化合物VIII (負離子為PFr 及ΒΓ) 110 雖然本發明已以較佳實施例揭露如上,然其並非用以限定本 發明,任何熟習此技藝者,在不脫離本發明之精神和範圍内, 當可作些許之更動與潤飾,因此本發明之保護範圍當視後附之 申請專利範圍所界定者為準。 0424-733 lTWF4;02900040;Phoebe 16 1286547 【圖式簡單說明】 無。 【符號說明】 無0Compound VI was measured by nuclear resonance (NMR) and far infrared (IR) with the following data: iHNMR (200 MHz, D20/DMS0_d6/ppm): 8_81 (s, 1H), 7.55 (m, 2H); 4.41 (m, 3.H (3,3H); (Prepared by compound VI) Compound VI (1.42g, 5.0mmol) was dissolved in 5ml of methanol, added D to 13 (0.47g, 6.0mmol), stirred for 14hr, then added with appropriate amount of acetone for 30 minutes to wash, then static After ice-cold bath for 20 minutes, it was quickly filtered, and then the solid was washed with acetone (5 ml), then the solid was collected in a reaction flask and drained in a vacuum pump to obtain Compound IV, which had the same 1H NMR data as in Example 1. The melting points of the prepared compounds II, IV, V, VI, VII and VIII are listed in the following table: 丨爹正1286547 I Replenish the teeth and then collect the solid in the reaction flask, IV in the vacuum pump, 1H NMR data and Example 1 The melting points of the above-prepared compounds II, IV, V, VI, VII and VIII are listed in the following table: Compound species melting point Tm (°C) Compound II 138 Compound IV (negative ion is Br~") 144 Compound V (negative ion is CF3COO-) 18 Compound VI 149 Compound V (negative ion is BF〇93 Compound VII (negative ion is PF") 126 Compound VIII (negative ion is PFr) And the present invention has been disclosed in the above preferred embodiments. However, it is not intended to limit the invention, and those skilled in the art can make some modifications and refinements without departing from the spirit and scope of the invention. Therefore, the scope of protection of the present invention is defined by the scope of the appended patent application. 0424-733 lTWF4; 02900040; Phoebe 16 1286547 [Simple description] None. [Symbol description] None 0

Claims (1)

修:Erff 斯 τ94τθ^.Repair: Erff s τ94τθ^. I286Wi 32421號申請專利範圍修正本 拾、申請專利範圍: 攀子熔體,其結構如下:I286Wi 32421 application for the scope of patent amendments, the scope of patent application: Panzi melt, its structure is as follows: 其中1為-(«12)^,其中X為1〜10之整數;R2為(^至c3烷基; 二個A為相同或不相同有機或無機化合物,及A·為R3C02_、 bf4_、或pf6_,其中r3為q〜C3烷基或CF3。 2.—種製備如申請專利範圍第1項所述之離子熔體的方 法,其包括: (a)將吡啶與具取代基B之烷類化合物反應而得一化合物 II ;Wherein 1 is -(«12)^, wherein X is an integer from 1 to 10; R2 is (^ to c3 alkyl; two A are the same or different organic or inorganic compounds, and A· is R3C02_, bf4_, or Pf6_, wherein r3 is q~C3 alkyl or CF3. 2. A method of preparing an ionic melt according to claim 1, which comprises: (a) a pyridine and a substituted alkyl group The compound is reacted to obtain a compound II; 化合物II 其中該具取代基B之烷類化合物之化學式為B_(CH2)X-B,其中 各B為相同或不同鹵素,擇自於F、C卜Br、及I所組成之群組, X為1〜10,及Ri為-(«12)广; (b)將化合物II純化後與具取代基R2之咪唑(化合物III)Compound II wherein the alkyl compound having the substituent B has the chemical formula B_(CH2)XB, wherein each B is the same or different halogen, and is selected from the group consisting of F, C, Br, and I, and X is 1 ~10, and Ri is -(«12) wide; (b) Purification of compound II with imidazole with substituent R2 (compound III) 1%^N~R2 化合物III 反應得到含有味唾鎗鹽(imidazolium salts)及吼唆鐺鹽 (pyridiniumsalts)的烧類化合物 IV ; 0424-733 lTWF4;02900040;Phoebe 18 12865471%^N~R2 Compound III is reacted to obtain a pyroline compound IV containing imidazolium salts and pyridinium salts; 0424-733 lTWF4; 02900040; Phoebe 18 1286547 化合物IV 其中R2為Ci〜C3烷基及各B為相同或不同; 以及 (C)將化合物IV與有機或無機之金屬化合物MA反應,而 得如化學式ν所示之離子炼體Wherein R2 is a Ci~C3 alkyl group and each B is the same or different; and (C) reacting the compound IV with an organic or inorganic metal compound MA to obtain an ion-refining body represented by the chemical formula ν 化合物V 其中該有機或無機之金屬化合物ΜΑ係擇自r3c〇2M、MBF4、 及MPF6所組成之群組,其中μ係擇自Ag、Li、Na、及K所組 成之組群’ r2為Cl〜C3烷基,&為Cl〜c3烷類或cf3。 3·—種製備如申請專利範圍第1項所述之離子熔體的方 法,其包括: (a)將具取代基r2之咪唑(化合物11;[)Compound V wherein the organic or inorganic metal compound is selected from the group consisting of r3c〇2M, MBF4, and MPF6, wherein the μ system is selected from the group consisting of Ag, Li, Na, and K, and r2 is Cl. ~C3 alkyl, & Cl~c3 alkane or cf3. 3. A method of preparing an ionic melt according to claim 1, which comprises: (a) an imidazole having a substituent r2 (Compound 11; [) 化合物III 與具取代基B之烷類化合物反應而得化合物VI ;Compound III is reacted with an alkane compound having a substituent B to obtain a compound VI; 化合物VI 其中該具取代基B之烷類化合物之化學式為B_(CH2)x_B,其中 0424-733 lTWF4;02900040;Phoebe 19 1286547 各B為相同或不同鹵素,擇自於F、C卜Br、及I所組成之群組, X為1〜10,及I為-(«12)^,R2為(^〜(33烷基; (b)將化合物VI純化後與吡啶反應得到含有咪唑鎗鹽 (imidazolium salts)及 口比 ΰ定鍚鹽(pyridinium salts)的烧類化合物 IV ;Compound VI wherein the alkyl compound having the substituent B has the chemical formula B_(CH2)x_B, wherein 0424-733 lTWF4; 02900040; Phoebe 19 1286547 each B is the same or different halogen, selected from F, C, Br, and A group consisting of I, X is 1 to 10, and I is -(«12)^, and R2 is (^~(33 alkyl; (b) the compound VI is purified and reacted with pyridine to obtain an imidazole salt ( Imidazolium salts) and pyrophoric pyridinium salts of pyrophoric compounds IV; ㊀ 2B 以及 (c)將化合物IV與有機或無機之金屬化合物A反應,而得 如化學式V所示之離子熔體a 2B and (c) reacting the compound IV with an organic or inorganic metal compound A to obtain an ionic melt as shown in the chemical formula V. 化合物V 其中該有機或無機之金屬化合物MA係擇自R3C02M、MBF4、 及MPF6所組成之群組,其中Μ係擇自Ag、Li、Na、及K所組 成之組群,R2為Ci〜C3烷基,R3為<^〜03烷類或CF3。 0424-733 lTWF4;02900040;Phoebe 20Compound V wherein the organic or inorganic metal compound MA is selected from the group consisting of R3C02M, MBF4, and MPF6, wherein the lanthanide is selected from the group consisting of Ag, Li, Na, and K, and R2 is Ci~C3. Alkyl, R3 is a <^~03 alkane or CF3. 0424-733 lTWF4; 02900040; Phoebe 20
TW90132421A 2001-12-26 2001-12-26 Ionic molten salt and method of producing the same TWI286547B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW90132421A TWI286547B (en) 2001-12-26 2001-12-26 Ionic molten salt and method of producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW90132421A TWI286547B (en) 2001-12-26 2001-12-26 Ionic molten salt and method of producing the same

Publications (1)

Publication Number Publication Date
TWI286547B true TWI286547B (en) 2007-09-11

Family

ID=39459328

Family Applications (1)

Application Number Title Priority Date Filing Date
TW90132421A TWI286547B (en) 2001-12-26 2001-12-26 Ionic molten salt and method of producing the same

Country Status (1)

Country Link
TW (1) TWI286547B (en)

Similar Documents

Publication Publication Date Title
JP5463140B2 (en) Method for producing ionic liquid
CN101570550B (en) Method for synthesizing chiral ferrocene diphosphine ligand
CN108380245B (en) Bidentate phosphorus-aza-carbene p-cymene type ruthenium complex catalyst, preparation method and synthesis application thereof
Ishii et al. Facile preparation of ionic liquid containing silsesquioxane framework
JP2011506468A (en) Process for producing and using heteroaryl salts and the same
TWI286547B (en) Ionic molten salt and method of producing the same
US20050065020A1 (en) Ionic liquids containing secondary hydroxyl-groups and a method for their preparation
JPS62238236A (en) Production of alkoxysalicylic acid derivative
CN108911937B (en) Synthesis method of tetraarylethylene compound
EP0108682B1 (en) Solvent free preparation of diarylthioethers
JP2005104846A (en) Quaternary ammonium ambient-temperature molten salt and its manufacturing method
JP6501351B2 (en) Fluoroalkane derivative, gelling agent, liquid crystalline compound and gel composition
JP4991744B2 (en) Production method of biphenyls
GB2101601A (en) Bisphosphine synthesis
KR101162713B1 (en) A Preparation Method For High Pure Ionic Liquid
JP6461942B2 (en) Monoarylation of aromatic amines.
US6239285B1 (en) Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
JP5407332B2 (en) Method for producing quarterpyridine derivative and its intermediate
JP2005325052A (en) Quaternary ammonium dicyanamide, method for producing the same and use thereof
CN104262271A (en) Preparing method and applications of tetra(4-triazolephenyl) pentaerythritol ether
JP2001106686A (en) Production of 5-lipoxygenase inhibitor having vraious heterocyclic ring systems
US6344563B1 (en) Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
Zou et al. Synthesis, Characterization and Properties of Amide Anions Based Ionic Liquids Containing Nitrile Group
Nohira et al. Optical resolution of 2-(4-substituted phenyl)-3-methylbutanoic acids with diethylamine by preferential crystallization
CN116063349A (en) Preparation method of axial chiral diphosphine monooxygen ligand

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent